Join today and have your say! It’s FREE!

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by HighSkies2019on Dec 18, 2020 9:54am
317 Views
Post# 32139153

Halt Lifted and Taxes

Halt Lifted and TaxesPersonally in Klys case this is the perfect time to go unhalted .... those that sell for tax loss purposes has to be in a non registered account.....investors that use a TFSA and any funds used from registered don't apply ....anyone selling will need to sell sufficient qtys to offset any gains or unless a heavy hitter investor that has lost in multiple stks....but they will not be able purchase back same stk untill 30 calendar days after their tax loss sale..... it could be a very risky play for some if Kly does come out with valuable NR ....and I dunno about anyone else....but I want Kly unhalted asap today would be great ...this is just imo ....glta
<< Previous
Bullboard Posts
Next >>